Dual-Action Niclosamide–Polysaccharide Nasal Spray for the Early Therapeutic Intervention of Respiratory Viral Infections
International Journal of Molecular Sciences · 16.06.2026 · 27 (12) · 5420
DOI: 10.3390/ijms27125420 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.06.2026. Verfasst von Jongseo Choi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Daewoong Pharmaceutical Co., Ltd., 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si 17028, Gyeonggi-do, Republic of Korea. Hauptthemen laut MEDLINE: Niclosamide, Antiviral Agents, Polysaccharides, Bacterial, Polysaccharides. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daewoong Pharmaceuticals Co., Ltd..
Abstract (Originalsprache)
Extensive efforts have been undertaken by numerous researchers to control respiratory viruses across the domains of diagnosis, prevention, and treatment. In this study, we developed a niclosamide–polysaccharide nasal spray (NPNS) formulation based on xanthan gum (XG), a naturally derived polysaccharide, and niclosamide, a conventional anthelmintic agent. We then evaluated its therapeutic efficacy following intranasal administration under influenza virus-infected conditions. NPNS was assessed for cytotoxicity under Good Laboratory Practice (GLP) conditions in accordance with ISO 10993-5, and no cytotoxic effects were observed. In influenza virus-infected human nasal epithelial cells (HNEc), NPNS treatment resulted in at least 92.5% suppression of viral gene expression. Furthermore, NPNS demonstrated significantly greater antiviral activity compared to Placebo 1 and Placebo 2, which were formulated by excluding niclosamide and XG, respectively. Owing to the physicochemical properties conferred by XG, NPNS exhibited prolonged retention on the nasal mucosa in a mouse model. Consistently, NPNS showed potent antiviral efficacy in influenza-infected mice. In addition, NPNS treatment was associated with the downregulation of S-phase kinase-associated protein 2 (SKP2), a host factor known to facilitate intracellular viral replication. Collectively, these findings suggest that NPNS may serve as a first-line protective barrier during the early stage of influenza infection by simultaneously blocking viral entry and suppressing viral replication through its dual physicochemical and molecular mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Daewoong Pharmaceutical Co., Ltd., 72 Dugye-ro, Pogok-eup, Cheoin-gu, Yongin-si 17028, Gyeonggi-do, Republic of Korea.
- College of Veterinary Medicine, Biosafety Research Institute and Core Facility Center for Zoonosis Research, Jeonbuk National University, 79 Gobong-ro, Iksan 54596, Jeollabuk-do, Republic of Korea.
- Department of Biohealth, Kunsan National University, 558 Daehak-ro, Gunsan 54150, Jeollabuk-do, Republic of Korea.
ORCID-Profile: Byeongyong Kim, Gwanyoung Kim
Förderung
- Daewoong Pharmaceuticals Co., Ltd.
Zitieren
APA
Choi, J., Lee, D., Na, Y., Kim, B., Cho, S., Lee, K., Chun, K., Kim, G., Eo, S. K., & Kim, S. (2026). Dual-Action Niclosamide–Polysaccharide Nasal Spray for the Early Therapeutic Intervention of Respiratory Viral Infections. International Journal of Molecular Sciences, 27(12), 5420. https://doi.org/10.3390/ijms27125420
Vancouver
Choi J, Lee D, Na Y, Kim B, Cho S, Lee K, et al. Dual-Action Niclosamide–Polysaccharide Nasal Spray for the Early Therapeutic Intervention of Respiratory Viral Infections. International Journal of Molecular Sciences. 2026;27(12):5420. doi:10.3390/ijms27125420
BibTeX
@article{Choi2026,
author = {Choi, Jongseo and Lee, Dongjin and Na, Yujeong and Kim, Byeongyong and Cho, Sangeun and Lee, Kyungmin and Chun, Kyeunghwa and Kim, Gwanyoung and Eo, Seong Kug and Kim, Sokho},
title = {Dual-Action Niclosamide–Polysaccharide Nasal Spray for the Early Therapeutic Intervention of Respiratory Viral Infections},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5420},
doi = {10.3390/ijms27125420}
}
EUVIMED